Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06260176 · ClinicalTrials.gov registry record · NA
Vending Labeling Sales and Intercepts Study
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,065
- Enrollment target
NCT06260176: Completed NA study, sponsored by University of Pennsylvania.
NCT06260176 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,065 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (24% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06260176, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,065 participants
- Enrollment target
Study Summary
The aim of this study is to compare the impact of 4 different types of front of package (FOP) food and beverage messages: 1) green labels on healthy foods, 2) red/yellow/green labels on less healthy/moderately healthy/healthy foods, 3) physical activity calorie equivalent labels, and 4) posters reminding consumers of the sweetened beverage tax on consumers' beverage and snack selections.
Primary Outcome
Outcome is percentage of monthly beverages selected that had calories
Interventions
- BEHAVIORAL exposure to healthy labels only
- BEHAVIORAL exposure to healthiness information
- BEHAVIORAL exposure to physical activity equivalents
- BEHAVIORAL exposure to sweetened beverage tax messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,065 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2020-03-12 |
| Phase | NA |
What the finished NCT06260176 record still lists
NCT06260176 is an interventional study that assigns participants to a tested intervention. Its 1,065 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (24% lower).
The record links to 0 conditions, and to 4 interventions - of which exposure to healthy labels only is the first listed.
NCT06260176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06260176 about?
NCT06260176 is a clinical study titled "Vending Labeling Sales and Intercepts Study". The aim of this study is to compare the impact of 4 different types of front of package (FOP) food and beverage messages: 1) green labels on healthy foods, 2) red/yellow/green labels on less healthy/moderately healthy/healthy foods, 3) physical activity calorie equivalent labels, and 4) posters remi...
What is the current status of trial NCT06260176?
This trial is currently completed. It is a NA study. The enrollment target is 1,065 participants. The study started on 2019-02-01. Estimated completion is 2020-03-12.
What interventions are being tested in trial NCT06260176?
The interventions under investigation include: exposure to healthy labels only (BEHAVIORAL), exposure to healthiness information (BEHAVIORAL), exposure to physical activity equivalents (BEHAVIORAL), exposure to sweetened beverage tax messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06260176?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06260176's enrollment target sits among peer trials
1,065 97th of 2000 higher than 1,904 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI